137 related articles for article (PubMed ID: 20093352)
1. Tumor response to sunitinib malate observed in clear-cell sarcoma.
Stacchiotti S; Grosso F; Negri T; Palassini E; Morosi C; Pilotti S; Gronchi A; Casali PG
Ann Oncol; 2010 May; 21(5):1130-1. PubMed ID: 20093352
[No Abstract] [Full Text] [Related]
2. Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas.
George S; Merriam P; Maki RG; Van den Abbeele AD; Yap JT; Akhurst T; Harmon DC; Bhuchar G; O'Mara MM; D'Adamo DR; Morgan J; Schwartz GK; Wagner AJ; Butrynski JE; Demetri GD; Keohan ML
J Clin Oncol; 2009 Jul; 27(19):3154-60. PubMed ID: 19451429
[TBL] [Abstract][Full Text] [Related]
3. Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report.
Tazzari M; Palassini E; Vergani B; Villa A; Rini F; Negri T; Colombo C; Crippa F; Morosi C; Casali PG; Pilotti S; Stacchiotti S; Rivoltini L; Castelli C
BMC Cancer; 2015 Feb; 15():58. PubMed ID: 25880253
[TBL] [Abstract][Full Text] [Related]
4. Sarcomatoid non-small cell lung cancer responding to sunitinib.
Schultheis B; Kummer G; Strumberg D
Int J Clin Pharmacol Ther; 2013 Jan; 51(1):87-8. PubMed ID: 23260010
[No Abstract] [Full Text] [Related]
5. ¹¹C-methionine positron-emission tomography and computed tomography (PET-CT) in evaluating metastatic transitional cell carcinoma response to sunitinib therapy.
Katz L; Choueiri TK; Bellmunt J
BJU Int; 2010 Nov; 106(9):1249-50. PubMed ID: 20963928
[No Abstract] [Full Text] [Related]
6. A giant clear cell sarcoma on right scapular: A case report.
Zhang X; Hu C; Cai L
Acta Orthop Traumatol Turc; 2016 Aug; 50(4):473-6. PubMed ID: 27452744
[TBL] [Abstract][Full Text] [Related]
7. Clear cell sarcoma of soft parts. A case report and review of the literature.
Reid-Nicholson MD; Williams EE; Brady-West DC
West Indian Med J; 2001 Mar; 50(1):78-80. PubMed ID: 11398297
[TBL] [Abstract][Full Text] [Related]
8. Combined sunitinib and radiation therapy for preoperative treatment of soft tissue sarcoma: results of a phase I trial of the German interdisciplinary sarcoma group (GISG-03).
Jakob J; Simeonova A; Kasper B; Ronellenfitsch U; Rauch G; Wenz F; Hohenberger P
Radiat Oncol; 2016 Jun; 11():77. PubMed ID: 27255678
[TBL] [Abstract][Full Text] [Related]
9. Sunitinib malate as the salvage therapy in advanced rectal carcinoid tumor.
Lu CC; Lin HF; Feng CC; Yu CY; Kao WY
Int J Colorectal Dis; 2008 Dec; 23(12):1265-6. PubMed ID: 18629516
[No Abstract] [Full Text] [Related]
10. Targeting BRAF mutants in clear-cell sarcomas of soft tissue: beyond sarcoma or melanoma classification.
Uguen A; Marcorelles P; De Braekeleer M
Invest New Drugs; 2016 Apr; 34(2):253-4. PubMed ID: 26746214
[No Abstract] [Full Text] [Related]
11. Major response to sunitinib (Sutene) in metastatic malignant phyllodes tumor of breast.
Park IH; Kwon Y; Kim EA; Lee KS; Ro J
Invest New Drugs; 2009 Aug; 27(4):387-8. PubMed ID: 19002383
[No Abstract] [Full Text] [Related]
12. Necrosis of a skin autograft after short-term treatment with sunitinib in a 14-year-old girl with metastatic alveolar soft part sarcoma of the thigh.
Hanzer M; Nebl A; Spendel S; Pilhatsch A; Urban C; Benesch M
Klin Padiatr; 2010 May; 222(3):184-6. PubMed ID: 20514624
[TBL] [Abstract][Full Text] [Related]
13. Clear cell sarcoma of soft tissues.
Malchau SS; Hayden J; Hornicek F; Mankin HJ
J Surg Oncol; 2007 May; 95(6):519-22. PubMed ID: 17192915
[TBL] [Abstract][Full Text] [Related]
14. Treatment of multidrug resistant advanced alveolar soft part sarcoma with sunitinib.
Ghose A; Tariq Z; Veltri S
Am J Ther; 2012 Jan; 19(1):e56-8. PubMed ID: 20634674
[TBL] [Abstract][Full Text] [Related]
15. Computed tomography characteristics of unresectable primary renal cell carcinoma treated with neoadjuvant sunitinib.
Salem ME; Shah SN; Elson P; Garcia JA; Wood LS; Medsinge A; Campbell S; Dreicer R; Rini BI
Clin Genitourin Cancer; 2014 Apr; 12(2):117-23. PubMed ID: 24126239
[TBL] [Abstract][Full Text] [Related]
16. F-18 FDG PET/CT assessment of gastrointestinal stromal tumor response to sunitinib malate therapy.
Banzo I; Quirce R; Martinez-Rodriguez I; Jimenez-Bonilla J; Sainz-Esteban A; Barragan J; Portilla-Quattrociocchi H; Carril JM
Clin Nucl Med; 2008 Mar; 33(3):211-2. PubMed ID: 18287850
[No Abstract] [Full Text] [Related]
17. [Advanced sarcomatoid renal cell carcinoma effectively treated with sunitinib: report of a case].
Tsuchiyama K; Ito H; Ishida H; Itoh H; Yokoyama O
Hinyokika Kiyo; 2011 Nov; 57(11):615-8. PubMed ID: 22166824
[TBL] [Abstract][Full Text] [Related]
18. Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect.
Stacchiotti S; Negri T; Zaffaroni N; Palassini E; Morosi C; Brich S; Conca E; Bozzi F; Cassinelli G; Gronchi A; Casali PG; Pilotti S
Ann Oncol; 2011 Jul; 22(7):1682-1690. PubMed ID: 21242589
[TBL] [Abstract][Full Text] [Related]
19. Metastatic mucinous tubular and spindle cell carcinoma of the kidney responding to sunitinib.
Larkin J; Fisher R; Pickering L; Thway K; Livni N; Fisher C; Gore M
J Clin Oncol; 2010 Oct; 28(28):e539-40. PubMed ID: 20679595
[No Abstract] [Full Text] [Related]
20. A differential response to sunitinib: sustained systemic response paralleled by intra-dural progression in the spine. Should standard response criteria be reviewed?
Jafri M; Porfiri E
Clin Genitourin Cancer; 2009 Aug; 7(2):E42-4. PubMed ID: 19692324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
